Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells

Jiang,Jiong; Dong,Lei; Qin,Bin; Shi,Haitao; Guo,Xiaoyan; Wang,Yan

doi:10.3892/ol.2016.4617

Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells

Authors:
- Jiong Jiang
- Lei Dong
- Bin Qin
- Haitao Shi
- Xiaoyan Guo
- Yan Wang
View Affiliations

Affiliations: Department of Gastroenterology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi 710003, P.R. China
Published online on: May 24, 2016 https://doi.org/10.3892/ol.2016.4617
Pages: 631-636

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to determine the expression of Toll-like receptor 7 (TLR7) in gastric cancer tissues and investigate the effects of its activation on gastric cancer cells. Patients with gastric cancer (n=30) and patients without gastric cancer (control; n=14) who underwent gastroscopy were enrolled in the study. Gastric cancer and cancer‑adjacent tissues were obtained from the patients with gastric cancer, and normal gastric epithelial tissues were obtained from the control patients. The TLR7 mRNA and protein expressions in different tissues were investigated by reverse transcription‑quantitative polymerase chain reaction, western blotting and immunohistochemistry. The present study also determined the effects of TLR7 activation by the agonist imiquimod on TLR7 protein expression, proinflammatory cytokine secretion and viability in SGC‑7901 gastric cancer cells. The mRNA and protein expression levels of TLR7 were significantly downregulated in gastric cancer tissues compared with cancer‑adjacent and normal gastric epithelial tissues (P<0.01). Imiquimod significantly increased TLR7 protein expression levels, and promoted the secretion of proinflammatory cytokines tumor necrosis factor‑α and interleukin‑6 in SGC‑7901 cells. Furthermore, imiquimod inhibited the proliferation of SGC‑7901 cells in a dose‑ and time‑dependent manner. Thus, the present study identified that the expression of TLR7 was decreased in gastric cancer tissues, and TLR7 activation enhanced TLR7 expression, promoted the production of proinflammatory cytokines and inhibited the growth of gastric cancer cells.

View Figures

View References

1	Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
2	Curtin JF, Liu N, Candolfi M, Xiong W, Assi H, Yagiz K, Edwards MR, Michelsen KS, Kroeger KM, Liu C, et al: HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 6:e102009. View Article : Google Scholar : PubMed/NCBI
3	Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF and Hoon DS: Activation of Toll-like receptors 2, 3 and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther. 7:3642–3653. 2008. View Article : Google Scholar : PubMed/NCBI
4	Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW and Selander KS: Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate. 67:774–781. 2007. View Article : Google Scholar : PubMed/NCBI
5	Xie W, Wang Y, Huang Y, Yang H, Wang J and Hu Z: Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun. 379:1027–1032. 2009. View Article : Google Scholar : PubMed/NCBI
6	Sato Y, Goto Y, Narita N and Hoon DS: Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenviron. 2(Suppl 1): S205–S214. 2009. View Article : Google Scholar
7	Wolska A, Lech-Marańda E and Robak T: Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett. 14:248–272. 2009. View Article : Google Scholar : PubMed/NCBI
8	Rakoff-Nahoum S and Medzhitov R: Toll-like receptors and cancer. Nat Rev Cancer. 9:57–63. 2009. View Article : Google Scholar : PubMed/NCBI
9	Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477. 2009. View Article : Google Scholar : PubMed/NCBI
10	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
11	Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L and He J: Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
12	Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
13	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
14	Killeen SD, Wang JH, Andrews EJ and Redmond HP: Exploitation of the Toll-like receptor system in cancer: A doubled-edged sword? Br J Cancer. 95:247–252. 2006. View Article : Google Scholar : PubMed/NCBI
15	Schmausser B, Andrulis M, Endrich S, Müller-Hermelink HK and Eck M: Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: An implication for interaction with helicobacter pylori. Int J Med Microbiol. 295:179–185. 2005. View Article : Google Scholar : PubMed/NCBI
16	Yi JY, Jung YJ, Choi SS, Hwang J and Chung E: Autophagy-mediated anti-tumoral activity of imiquimod in Caco-2 cells. Biochem Biophys Res Commun. 386:455–458. 2009. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Cherfils-Vicini J, Platonova S, Gillard M, Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F, Dieu-Nosjean MC, Fridman WH, et al: Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest. 120:1285–1297. 2010. View Article : Google Scholar : PubMed/NCBI
19	Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H and Wang H: Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol. 17:3745–3751. 2011. View Article : Google Scholar : PubMed/NCBI
20	Eiró N, González L, González LO, Andicoechea A, Fernández-Díaz M, Altadill A and Vizoso FJ: Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer. J Clin Immunol. 32:848–854. 2012. View Article : Google Scholar : PubMed/NCBI
21	Han JH, Park SY, Kim JB, Cho SD, Kim B, Kim BY, Kang MJ, Kim DJ and Park JH and Park JH: TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells. Am J Reprod Immunol. 70:317–326. 2013. View Article : Google Scholar : PubMed/NCBI
22	Lin KJ, Lin TM, Wang CH, Liu HC, Lin YL and Eng HL: Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma. Hum Pathol. 44:534–541. 2013. View Article : Google Scholar : PubMed/NCBI
23	Sligh JE Jr: New therapeutic options for actinic keratosis and basal cell carcinoma. Semin Cutan Med Surg. 33(Suppl 4): S76–S80. 2014. View Article : Google Scholar : PubMed/NCBI
24	Yu L and Chen S: Toll-like receptors expressed in tumor cells: Targets for therapy. Cancer Immunol Immunother. 57:1271–1278. 2008. View Article : Google Scholar : PubMed/NCBI
25	Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T and Mor G: TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in cancer. Cancer Res. 66:3859–3868. 2006. View Article : Google Scholar : PubMed/NCBI
26	Smith MF Jr, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S and Goldberg JB: Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem. 278:32552–32560. 2003. View Article : Google Scholar : PubMed/NCBI
27	Huang SW, Liu KT, Chang CC, Chen YJ, Wu CY, Tsai JJ, Lu WC, Wang YT, Liu CM and Shieh JJ: Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells. Br J Dermatol. 163:310–320. 2010. View Article : Google Scholar : PubMed/NCBI
28	Aspord C, Tramcourt L, Leloup C, Molens JP, Leccia MT, Charles J and Plumas J: Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization. J Invest Dermatol. 134:2551–2561. 2014. View Article : Google Scholar : PubMed/NCBI